Is Ottawa’s ‘supercluster’ funding initiative a superboondoggle in the making?
Ottawa’s plan to improve productivity and innovation through the promotion of five regional economic groups is both ambitious and expensive. It may provide the spark the country needs – unless it proves to be a fat subsidy for global technology giants
DNA on drugs: How genetic tests could make prescriptions more precise
It’s well known that different people can react differently to the same drug, with some patients feeling no effect – and some experiencing unwanted, even fatal, reactions. Now that reading patients’ DNA has become cheap and easy, pressure is mounting to make gene-guided prescriptions a regular part of publicly funded medicine
Cracks in the code: Why mapping your DNA may be less reliable than you think
The Personal Genome Project was supposed to revolutionize medicine, but the results reveal how much we still have to learn. Carolyn Abraham looks at the risk of misleading results as DNA testing enters mainstream medicine